TreeWAS – Variant ID: rs35640778

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	No effect posterior probability	Protective posterior probability
Chapter II Neoplasms	0.000	1.000
R30-R39 Symptoms and signs involving the urinary system	0.000	1.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.000	1.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.000	1.000
R33 Retention of urine	0.000	1.000
C44 Other malignant neoplasms of skin	0.000	1.000
C60-C63 Malignant neoplasms of male genital organs	0.001	0.999
C61 Malignant neoplasm of prostate	0.001	0.999
R31 Unspecified haematuria	0.003	0.997
C79 Secondary malignant neoplasm of other sites	0.012	0.988
D10-D36 Benign neoplasms	0.014	0.986
C44.5 Skin of trunk	0.015	0.985
D22 Melanocytic naevi	0.018	0.982
C44.3 Skin of other and unspecified parts of face	0.019	0.981
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.021	0.979
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.027	0.973
R32 Unspecified urinary incontinence	0.036	0.964
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.037	0.963
R39 Other symptoms and signs involving the urinary system	0.046	0.954
D22.5 Melanocytic naevi of trunk	0.047	0.953
Z85 Personal history of malignant neoplasm	0.051	0.949
Z85.8 Personal history of malignant neoplasms of other organs and systems	0.052	0.948
Z80-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status	0.053	0.947
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	0.054	0.946
Z92 Personal history of medical treatment	0.059	0.941
D22.7 Melanocytic naevi of lower limb, including hip	0.063	0.937
Z92.6 Personal history of chemotherapy for neoplastic disease	0.066	0.934
D17 Benign lipomatous neoplasm	0.068	0.932
Z92.3 Personal history of irradiation	0.074	0.926
Z80 Family history of malignant neoplasm	0.079	0.921
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.079	0.921
C78.0 Secondary malignant neoplasm of lung	0.091	0.909
C77.3 Axillary and upper limb lymph nodes	0.092	0.908
C43 Malignant melanoma of skin	0.092	0.908
C50-C50 Malignant neoplasm of breast	0.093	0.907
R39.1 Other difficulties with micturition	0.095	0.905
R30 Pain associated with micturition	0.099	0.901
R35 Polyuria	0.101	0.899
# Top node	0.111	0.889
Z80.3 Family history of malignant neoplasm of breast	0.112	0.888
R21 Rash and other nonspecific skin eruption	0.112	0.888
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.112	0.888
Z96 Presence of other functional implants	0.119	0.881
D23 Other benign neoplasms of skin	0.119	0.881
C77.5 Intrapelvic lymph nodes	0.119	0.881
C44.4 Skin of scalp and neck	0.121	0.879
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.122	0.878
Chapter XXI Factors influencing health status and contact with health services	0.123	0.877
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.126	0.874
C44.1 Skin of eyelid, including canthus	0.129	0.871
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.130	0.870
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.131	0.869
D22.6 Melanocytic naevi of upper limb, including shoulder	0.131	0.869
Z85.4 Personal history of malignant neoplasm of genital organs	0.135	0.865
Chapter XIV Diseases of the genitourinary system	0.140	0.860
Z96.0 Presence of urogenital implants	0.140	0.860
N30-N39 Other diseases of urinary system	0.158	0.842
C50 Malignant neoplasm of breast	0.159	0.841
C79.7 Secondary malignant neoplasm of adrenal gland	0.161	0.839
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.163	0.837
C43.6 Malignant melanoma of upper limb, including shoulder	0.169	0.831
N32 Other disorders of bladder	0.169	0.831
R30.0 Dysuria	0.169	0.831
C44.0 Skin of lip	0.176	0.824
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.180	0.820
N10-N16 Renal tubulo-interstitial diseases	0.183	0.817
N32.8 Other specified disorders of bladder	0.187	0.813
C78.2 Secondary malignant neoplasm of pleura	0.187	0.813
Z85.5 Personal history of malignant neoplasm of urinary tract	0.187	0.813
D18 Haemangioma and lymphangioma, any site	0.193	0.807
Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung	0.196	0.804
Z80.4 Family history of malignant neoplasm of genital organs	0.201	0.799
C77.2 Intra-abdominal lymph nodes	0.204	0.796
Z85.6 Personal history of leukaemia	0.207	0.793
R70-R79 Abnormal findings on examination of blood, without diagnosis	0.209	0.791
D60-D64 Aplastic and other anaemias	0.213	0.787
Z99.2 Dependence on renal dialysis	0.219	0.781
C77.1 Intrathoracic lymph nodes	0.220	0.780
R20 Disturbances of skin sensation	0.221	0.779
C51-C58 Malignant neoplasms of female genital organs	0.223	0.777
D34 Benign neoplasm of thyroid gland	0.224	0.776
D22.1 Melanocytic naevi of eyelid, including canthus	0.224	0.776
C73 Malignant neoplasm of thyroid gland	0.224	0.776
R39.8 Other and unspecified symptoms and signs involving the urinary system	0.226	0.774
R10-R19 Symptoms and signs involving the digestive system and abdomen	0.238	0.762
Z80.0 Family history of malignant neoplasm of digestive organs	0.242	0.758
N35 Urethral stricture	0.243	0.757
C80 Malignant neoplasm without specification of site	0.244	0.756
D23.6 Skin of upper limb, including shoulder	0.245	0.755
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.245	0.755
D00-D09 In situ neoplasms	0.252	0.747
D64 Other anaemias	0.253	0.747
Z99.3 Dependence on wheelchair	0.255	0.745
Z97 Presence of other devices	0.257	0.743
C43.7 Malignant melanoma of lower limb, including hip	0.258	0.742
Chapter VI Diseases of the nervous system	0.262	0.738
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.262	0.738
C44.6 Skin of upper limb, including shoulder	0.265	0.735
Z94 Transplanted organ and tissue status	0.268	0.731
C50.3 Lower-inner quadrant of breast	0.273	0.727
R12 Heartburn	0.273	0.727
D17.9 Benign lipomatous neoplasm, unspecified	0.275	0.725
R47-R49 Symptoms and signs involving speech and voice	0.279	0.721
D23.1 Skin of eyelid, including canthus	0.279	0.721
D64.9 Anaemia, unspecified	0.282	0.718
R36 Urethral discharge	0.283	0.717
R34 Anuria and oliguria	0.283	0.717
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.283	0.717
C40-C41 Malignant neoplasms of bone and articular cartilage	0.283	0.717
C76 Malignant neoplasm of other and ill-defined sites	0.283	0.717
C44.9 Malignant neoplasm of skin, unspecified	0.283	0.717
C44.8 Overlapping lesion of skin	0.283	0.717
C63 Malignant neoplasm of other and unspecified male genital organs	0.284	0.716
C60 Malignant neoplasm of penis	0.284	0.716
N60-N64 Disorders of breast	0.286	0.714
Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs	0.287	0.713
N13 Obstructive and reflux uropathy	0.289	0.711
C50.9 Breast, unspecified	0.291	0.709
C79.6 Secondary malignant neoplasm of ovary	0.292	0.708
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.292	0.708
C79.2 Secondary malignant neoplasm of skin	0.292	0.708
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.292	0.708
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.292	0.708
D31 Benign neoplasm of eye and adnexa	0.293	0.707
D30 Benign neoplasm of urinary organs	0.293	0.707
D29 Benign neoplasm of male genital organs	0.293	0.707
D28 Benign neoplasm of other and unspecified female genital organs	0.293	0.707
D26 Other benign neoplasms of uterus	0.293	0.707
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.293	0.707
D19 Benign neoplasm of mesothelial tissue	0.293	0.707
D16 Benign neoplasm of bone and articular cartilage	0.293	0.707
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.293	0.707
R50-R69 General symptoms and signs	0.294	0.706
C44.2 Skin of ear and external auricular canal	0.295	0.705
D22.9 Melanocytic naevi, unspecified	0.296	0.704
D22.2 Melanocytic naevi of ear and external auricular canal	0.296	0.704
D22.0 Melanocytic naevi of lip	0.296	0.704
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.296	0.703
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.298	0.702
C78.4 Secondary malignant neoplasm of small intestine	0.298	0.702
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.298	0.702
C78.1 Secondary malignant neoplasm of mediastinum	0.298	0.702
C77.8 Lymph nodes of multiple regions	0.302	0.697
C77.4 Inguinal and lower limb lymph nodes	0.302	0.697
D11 Benign neoplasm of major salivary glands	0.303	0.697
D70-D77 Other diseases of blood and blood-forming organs	0.303	0.697
N35.9 Urethral stricture, unspecified	0.304	0.696
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.305	0.695
R20.2 Paraesthesia of skin	0.305	0.695
D21 Other benign neoplasms of connective and other soft tissue	0.306	0.694
C64-C68 Malignant neoplasms of urinary tract	0.306	0.694
C79.9 Secondary malignant neoplasm, unspecified site	0.307	0.693
N32.3 Diverticulum of bladder	0.307	0.693
Z80.8 Family history of malignant neoplasm of other organs or systems	0.307	0.693
C50.1 Central portion of breast	0.309	0.691
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.310	0.690
N20-N23 Urolithiasis	0.311	0.689
D27 Benign neoplasm of ovary	0.314	0.686
Z96.7 Presence of other bone and tendon implants	0.315	0.684
D23.4 Skin of scalp and neck	0.316	0.684
R39.2 Extrarenal uraemia	0.316	0.684
R39.0 Extravasation of urine	0.316	0.684
Z85.0 Personal history of malignant neoplasm of digestive organs	0.320	0.680
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.321	0.679
Z84 Family history of other conditions	0.321	0.679
Z81 Family history of mental and behavioural disorders	0.321	0.679
D18.0 Haemangioma, any site	0.322	0.678
R95-R99 Ill-defined and unknown causes of mortality	0.322	0.678
Z92.1 Personal history of long-term (current) use of anticoagulants	0.322	0.678
N25-N29 Other disorders of kidney and ureter	0.322	0.678
N32.0 Bladder-neck obstruction	0.323	0.677
N13.3 Other and unspecified hydronephrosis	0.324	0.676
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.325	0.675
Z92.9 Personal history of medical treatment, unspecified	0.325	0.675
Z92.8 Personal history of other medical treatment	0.325	0.675
Z92.5 Personal history of rehabilitation measures	0.325	0.675
Chapter XXII Codes for special purposes	0.326	0.674
C50.5 Lower-outer quadrant of breast	0.326	0.674
D14 Benign neoplasm of middle ear and respiratory system	0.326	0.674
Z93 Artificial opening status	0.326	0.674
R13 Dysphagia	0.331	0.669
Z88 Personal history of allergy to drugs, medicaments and biologocal substances	0.332	0.668
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.332	0.668
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.332	0.668
R53 Malaise and fatigue	0.334	0.666
D23.3 Skin of other and unspecified parts of face	0.335	0.665
Z96.8 Presence of other specified functional implants	0.335	0.664
D63 Anaemia in chronic diseases classified elsewhere	0.339	0.661
Z80.7 Family history of malignant neoplasms of lymphoid, haematopoietic and related tissues	0.339	0.660
Z80.6 Family history of leukaemia	0.339	0.660
Z80.5 Family history of malignant neoplasm of urinary tract	0.339	0.660
Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs	0.339	0.660
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.342	0.658
D37-D48 Neoplasms of uncertain or unknown behaviour	0.345	0.655
Z92.0 Personal history of contraception	0.347	0.653
C43.9 Malignant melanoma of skin, unspecified	0.349	0.651
C43.8 Overlapping malignant melanoma of skin	0.349	0.651
C43.2 Malignant melanoma of ear and external auricular canal	0.349	0.651
C43.1 Malignant melanoma of eyelid, including canthus	0.349	0.651
C43.0 Malignant melanoma of lip	0.349	0.651
G90-G99 Other disorders of the nervous system	0.350	0.650
C43.5 Malignant melanoma of trunk	0.350	0.650
Z88.8 Personal history of allergy to other drugs, medicaments and biological substances	0.352	0.648
R30.9 Painful micturition, unspecified	0.354	0.646
R30.1 Vesical tenesmus	0.354	0.646
Z99.1 Dependence on respirator	0.355	0.644
D33 Benign neoplasm of brain and other parts of central nervous system	0.356	0.644
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.357	0.643
D35 Benign neoplasm of other and unspecified endocrine glands	0.357	0.643
C77.0 Lymph nodes of head, face and neck	0.358	0.642
R79 Other abnormal findings of blood chemistry	0.358	0.642
C44.7 Skin of lower limb, including hip	0.359	0.641
G20-G26 Extrapyramidal and movement disorders	0.359	0.641
Chapter XVI Certain conditions originating in the perinatal period	0.363	0.637
Z98 Other postsurgical states	0.364	0.636
D70 Agranulocytosis	0.364	0.636
C43.3 Malignant melanoma of other and unspecified parts of face	0.367	0.633
D23.9 Skin, unspecified	0.368	0.632
D23.0 Skin of lip	0.368	0.632
Z96.9 Presence of functional implant, unspecified	0.368	0.632
Z96.5 Presence of tooth-root and mandibular implants	0.368	0.632
Z96.4 Presence of endocrine implants	0.368	0.632
Z96.3 Presence of artificial larynx	0.368	0.632
Z96.2 Presence of otological and audiological implants	0.368	0.632
D32 Benign neoplasm of meninges	0.369	0.631
N17-N19 Renal failure	0.369	0.631
Z99.9 Dependence on unspecified enabling machine and device	0.370	0.630
Z99.8 Dependence on other enabling machines and devices	0.370	0.630
Z99.4 Dependence on artificial heart	0.370	0.630
Z99.0 Dependence on aspirator	0.370	0.630
D80-D89 Certain disorders involving the immune mechanism	0.372	0.628
C78.7 Secondary malignant neoplasm of liver	0.372	0.628
N30 Cystitis	0.372	0.628
N23 Unspecified renal colic	0.373	0.627
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.374	0.625
C50.4 Upper-outer quadrant of breast	0.376	0.624
C75 Malignant neoplasm of other endocrine glands and related structures	0.377	0.623
C74 Malignant neoplasm of adrenal gland	0.377	0.623
C54 Malignant neoplasm of corpus uteri	0.378	0.621
D24 Benign neoplasm of breast	0.379	0.621
R23 Other skin changes	0.379	0.621
D10 Benign neoplasm of mouth and pharynx	0.379	0.620
R72 Abnormality of white blood cells, not elsewhere classified	0.380	0.620
D06 Carcinoma in situ of cervix uteri	0.381	0.619
D23.7 Skin of lower limb, including hip	0.381	0.619
Z89 Acquired absence of limb	0.382	0.618
R73 Elevated blood glucose level	0.383	0.617
D23.5 Skin of trunk	0.386	0.614
N36 Other disorders of urethra	0.387	0.613
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.389	0.611
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.392	0.607
G80-G83 Cerebral palsy and other paralytic syndromes	0.392	0.608
N37 Urethral disorders in diseases classified elsewhere	0.396	0.604
N34 Urethritis and urethral syndrome	0.396	0.604
N33 Bladder disorders in diseases classified elsewhere	0.396	0.604
C50.6 Axillary tail of breast	0.397	0.603
C50.0 Nipple and areola	0.397	0.603
C62 Malignant neoplasm of testis	0.398	0.602
R90-R94 Abnormal findings on diagnostic imaging and in function studies, without diagnosis	0.398	0.602
C56 Malignant neoplasm of ovary	0.398	0.602
D17.6 Benign lipomatous neoplasm of spermatic cord	0.400	0.600
D55-D59 Haemolytic anaemias	0.400	0.600
C80.0 Malignant neoplasm, primary site unknown, so stated	0.403	0.597
N32.4 Rupture of bladder, nontraumatic	0.404	0.596
N32.2 Vesical fistula, not elsewhere classified	0.404	0.596
N32.1 Vesicointestinal fistula	0.404	0.596
Z97.8 Presence of other specified devices	0.405	0.594
Z94.0 Kidney transplant status	0.407	0.593
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.408	0.592
C43.4 Malignant melanoma of scalp and neck	0.409	0.591
Z91 Personal history of risk-factors, not elsewhere classified	0.413	0.587
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.414	0.586
N15 Other renal tubulo-interstitial diseases	0.414	0.586
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.414	0.586
N11 Chronic tubulo-interstitial nephritis	0.414	0.586
R51 Headache	0.415	0.585
R50 Fever of unknown origin	0.417	0.583
R18 Ascites	0.420	0.580
R14 Flatulence and related conditions	0.420	0.580
D23.2 Skin of ear and external auricular canal	0.420	0.580
Z96.6 Presence of orthopaedic joint implants	0.421	0.579
D18.1 Lymphangioma, any site	0.421	0.579
D22.3 Melanocytic naevi of other and unspecified parts of face	0.422	0.578
R47 Speech disturbances, not elsewhere classified	0.423	0.577
Z97.5 Presence of (intra-uterine) contraceptive device	0.426	0.574
C50.8 Overlapping lesion of breast	0.426	0.574
R22.2 Localised swelling, mass and lump, trunk	0.428	0.572
D36 Benign neoplasm of other and unspecified sites	0.429	0.571
N64 Other disorders of breast	0.430	0.570
G20 Parkinson's disease	0.432	0.568
N10 Acute tubulo-interstitial nephritis	0.433	0.567
R78 Findings of drugs and other substances, not normally found in blood	0.433	0.567
R77 Other abnormalities of plasma proteins	0.433	0.567
R74 Abnormal serum enzyme levels	0.433	0.567
R75 Laboratory evidence of human immunodeficiency virus [HIV]	0.433	0.567
R71 Abnormality of red blood cells	0.433	0.567
C79.8 Secondary malignant neoplasm of other specified sites	0.434	0.565
R56 Convulsions, not elsewhere classified	0.435	0.565
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.435	0.564
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis	0.437	0.562
Z94.8 Other transplanted organ and tissue status	0.440	0.560
R20.3 Hyperaesthesia	0.441	0.559
R20.1 Hypoaesthesia of skin	0.441	0.559
R20.0 Anaesthesia of skin	0.441	0.559
R79.8 Other specified abnormal findings of blood chemistry	0.441	0.559
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.442	0.557
C57 Malignant neoplasm of other and unspecified female genital organs	0.443	0.557
C51 Malignant neoplasm of vulva	0.443	0.557
C58 Malignant neoplasm of placenta	0.443	0.557
C55 Malignant neoplasm of uterus, part unspecified	0.443	0.557
C52 Malignant neoplasm of vagina	0.443	0.557
N32.9 Bladder disorder, unspecified	0.444	0.556
G99 Other disorders of nervous system in diseases classified elsewhere	0.444	0.556
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.445	0.555
R76 Other abnormal immunological findings in serum	0.445	0.554
N60 Benign mammary dysplasia	0.446	0.554
N18 Chronic renal failure	0.447	0.553
R19 Other symptoms and signs involving the digestive system and abdomen	0.449	0.551
N62 Hypertrophy of breast	0.450	0.550
D09 Carcinoma in situ of other and unspecified sites	0.451	0.549
D22.4 Melanocytic naevi of scalp and neck	0.453	0.546
N28 Other disorders of kidney and ureter, not elsewhere classified	0.453	0.547
N35.8 Other urethral stricture	0.457	0.543
N35.1 Postinfective urethral stricture, not elsewhere classified	0.457	0.543
N35.0 Posttraumatic urethral stricture	0.457	0.543
Z80.9 Family history of malignant neoplasm, unspecified	0.457	0.543
D05 Carcinoma in situ of breast	0.461	0.538
N99-N99 Other disorders of the genitourinary system	0.462	0.538
D45 Polycythaemia vera	0.464	0.536
D02 Carcinoma in situ of middle ear and respiratory system	0.464	0.536
D01 Carcinoma in situ of other and unspecified digestive organs	0.464	0.536
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.464	0.536
D64.8 Other specified anaemias	0.464	0.536
D64.4 Congenital dyserythropoietic anaemia	0.464	0.536
D64.3 Other sideroblastic anaemias	0.464	0.536
D64.2 Secondary sideroblastic anaemia due to drugs and toxins	0.464	0.536
D64.1 Secondary sideroblastic anaemia due to disease	0.464	0.536
D64.0 Hereditary sideroblastic anaemia	0.464	0.536
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung	0.466	0.534
D62 Acute posthaemorrhagic anaemia	0.467	0.533
Z97.3 Presence of spectacles and contact lenses	0.467	0.532
Z97.2 Presence of dental prosthetic device (complete)(partial)	0.467	0.532
Z97.1 Presence of artificial limb (complete)(partial)	0.467	0.532
Z97.0 Presence of artificial eye	0.467	0.532
R22.1 Localised swelling, mass and lump, neck	0.468	0.532
D63.0 Anaemia in neoplastic disease	0.468	0.532
D63.8 Anaemia in other chronic diseases classified elsewhere	0.469	0.531
G00-G09 Inflammatory diseases of the central nervous system	0.471	0.529
G81 Hemiplegia	0.472	0.528
D03 Melanoma in situ	0.472	0.527
C67 Malignant neoplasm of bladder	0.473	0.527
D06.9 Cervix, unspecified	0.473	0.527
D68 Other coagulation defects	0.473	0.527
Z93.6 Other artificial openings of urinary tract status	0.474	0.526
N30.3 Trigonitis	0.474	0.526
D25 Leiomyoma of uterus	0.474	0.526
G93 Other disorders of brain	0.475	0.525
N13.5 Kinking and stricture of ureter without hydronephrosis	0.475	0.525
Z94.9 Transplanted organ and tissue status, unspecified	0.475	0.524
Z94.7 Corneal transplant status	0.475	0.524
Z94.6 Bone transplant status	0.475	0.524
Z94.5 Skin transplant status	0.475	0.524
Z94.3 Heart and lungs transplant status	0.475	0.524
Z94.2 Lung transplant status	0.475	0.524
Z94.1 Heart transplant status	0.475	0.524
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity	0.477	0.523
Z85.9 Personal history of malignant neoplasm, unspecified	0.477	0.523
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.479	0.520
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.479	0.520
R16.1 Splenomegaly, not elsewhere classified	0.479	0.520
G63 Polyneuropathy in diseases classified elsewhere	0.480	0.520
C80.9 Malignant neoplasm, unspecified	0.480	0.520
N00-N08 Glomerular diseases	0.482	0.518
D72 Other disorders of white blood cells	0.482	0.518
G91 Hydrocephalus	0.482	0.517
R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified	0.483	0.517
C77.9 Lymph node, unspecified	0.484	0.516
N13.9 Obstructive and reflux uropathy, unspecified	0.485	0.515
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.486	0.514
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.486	0.514
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.486	0.514
C97 Malignant neoplasms of independent (primary) multiple sites	0.486	0.514
C76.8 Overlapping lesion of other and ill-defined sites	0.486	0.514
C76.7 Other ill-defined sites	0.486	0.514
C76.5 Lower limb	0.486	0.514
C76.4 Upper limb	0.486	0.514
C76.3 Pelvis	0.486	0.514
C76.2 Abdomen	0.486	0.514
C76.1 Thorax	0.486	0.514
C76.0 Head, face and neck	0.486	0.514
R20.8 Other and unspecified disturbances of skin sensation	0.486	0.514
C60.9 Penis, unspecified	0.486	0.514
C60.8 Overlapping lesion of penis	0.486	0.514
C60.2 Body of penis	0.486	0.514
C60.1 Glans penis	0.486	0.514
C60.0 Prepuce	0.486	0.514
C63.9 Male genital organ, unspecified	0.486	0.514
C63.8 Overlapping lesion of male genital organs	0.486	0.514
C63.7 Other specified male genital organs	0.486	0.514
C63.2 Scrotum	0.486	0.514
C63.1 Spermatic cord	0.486	0.514
C63.0 Epididymis	0.486	0.514
Z88.5 Personal history of allergy to narcotic agent	0.487	0.513
G70-G73 Diseases of myoneural junction and muscle	0.488	0.512
R22.4 Localised swelling, mass and lump, lower limb	0.490	0.510
N13.7 Vesicoureteral-reflux-associated uropathy	0.490	0.510
N13.6 Pyonephrosis	0.490	0.510
N13.4 Hydroureter	0.490	0.510
R60 Oedema, not elsewhere classified	0.490	0.510
C54.1 Endometrium	0.490	0.510
Z88.4 Personal history of allergy to anaesthetic agent	0.491	0.509
D15.9 Intrathoracic organ, unspecified	0.493	0.507
D15.7 Other specified intrathoracic organs	0.493	0.507
D15.2 Mediastinum	0.493	0.507
D15.1 Heart	0.493	0.507
D15.0 Thymus	0.493	0.507
D16.9 Bone and articular cartilage, unspecified	0.493	0.507
D16.8 Pelvic bones, sacrum and coccyx	0.493	0.507
D16.7 Ribs, sternum and clavicle	0.493	0.507
D16.6 Vertebral column	0.493	0.507
D16.5 Lower jaw bone	0.493	0.507
D16.4 Bones of skull and face	0.493	0.507
D16.3 Short bones of lower limb	0.493	0.507
D16.2 Long bones of lower limb	0.493	0.507
D16.1 Short bones of upper limb	0.493	0.507
D16.0 Scapula and long bones of upper limb	0.493	0.507
D19.9 Mesothelial tissue, unspecified	0.493	0.507
D19.7 Mesothelial tissue of other sites	0.493	0.507
D19.1 Mesothelial tissue of peritoneum	0.493	0.507
D19.0 Mesothelial tissue of pleura	0.493	0.507
D20.1 Peritoneum	0.493	0.507
D20.0 Retroperitoneum	0.493	0.507
D26.9 Uterus, unspecified	0.493	0.507
D26.7 Other parts of uterus	0.493	0.507
D26.1 Corpus uteri	0.493	0.507
D26.0 Cervix uteri	0.493	0.507
D28.9 Female genital organ, unspecified	0.493	0.507
D28.7 Other specified female genital organs	0.493	0.507
D28.2 Uterine tubes and ligaments	0.493	0.507
D28.1 Vagina	0.493	0.507
D28.0 Vulva	0.493	0.507
D29.9 Male genital organ, unspecified	0.493	0.507
D29.7 Other male genital organs	0.493	0.507
D29.4 Scrotum	0.493	0.507
D29.3 Epididymis	0.493	0.507
D29.2 Testis	0.493	0.507
D29.1 Prostate	0.493	0.507
D29.0 Penis	0.493	0.507
D30.9 Urinary organ, unspecified	0.493	0.507
D30.7 Other urinary organs	0.493	0.507
D30.4 Urethra	0.493	0.507
D30.3 Bladder	0.493	0.507
D30.2 Ureter	0.493	0.507
D30.1 Renal pelvis	0.493	0.507
D30.0 Kidney	0.493	0.507
D31.9 Eye, unspecified	0.493	0.507
D31.6 Orbit, unspecified	0.493	0.507
D31.5 Lachrymal gland and duct	0.493	0.507
D31.4 Ciliary body	0.493	0.507
D31.3 Choroid	0.493	0.507
D31.2 Retina	0.493	0.507
D31.1 Cornea	0.493	0.507
D31.0 Conjunctiva	0.493	0.507
Z93.3 Colostomy status	0.493	0.507
R68 Other general symptoms and signs	0.494	0.506
R65 Systemic Inflammatory Response Syndrome [SIRS]	0.494	0.506
R62 Lack of expected normal physiological development	0.494	0.506
R57 Shock, not elsewhere classified	0.494	0.506
R64 Cachexia	0.494	0.506
R58 Haemorrhage, not elsewhere classified	0.494	0.506
D17.7 Benign lipomatous neoplasm of other sites	0.495	0.505
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.496	0.504
C64 Malignant neoplasm of kidney, except renal pelvis	0.496	0.504
N30.9 Cystitis, unspecified	0.496	0.504
G35-G37 Demyelinating diseases of the central nervous system	0.497	0.503
R69 Unknown and unspecified causes of morbidity	0.498	0.502
Z93.0 Tracheostomy status	0.498	0.502
N61 Inflammatory disorders of breast	0.499	0.501
D11.9 Major salivary gland, unspecified	0.500	0.500
D11.7 Other major salivary glands	0.500	0.500
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system	0.500	0.500
D74 Methaemoglobinaemia	0.500	0.500
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere	0.500	0.500
D71 Functional disorders of polymorphonuclear neutrophils	0.500	0.500
R73.9 Hyperglycaemia, unspecified	0.501	0.499
N63 Unspecified lump in breast	0.501	0.499
R22.7 Localised swelling, mass and lump, multiple sites	0.501	0.498
D07 Carcinoma in situ of other and unspecified genital organs	0.502	0.498
D21.9 Connective and other soft tissue, unspecified	0.502	0.497
D21.6 Connective and other soft tissue of trunk, unspecified	0.502	0.497
D21.5 Connective and other soft tissue of pelvis	0.502	0.497
D21.4 Connective and other soft tissue of abdomen	0.502	0.497
D21.3 Connective and other soft tissue of thorax	0.502	0.497
D21.2 Connective and other soft tissue of lower limb, including hip	0.502	0.497
D21.0 Connective and other soft tissue of head, face and neck	0.502	0.497
C68 Malignant neoplasm of other and unspecified urinary organs	0.502	0.497
C66 Malignant neoplasm of ureter	0.502	0.497
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.505	0.495
C71 Malignant neoplasm of brain	0.505	0.495
C70 Malignant neoplasm of meninges	0.505	0.495

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations